Zealand Pharma AS (OCSE:ZEAL)
kr 827 -18 (-2.13%) Market Cap: 58.67 Bil Enterprise Value: 50.13 Bil PE Ratio: 0 PB Ratio: 6.38 GF Score: 61/100

Q4 2018 Zealand Pharma A/S Earnings Call Transcript

Mar 07, 2019 / 03:00PM GMT
Release Date Price: kr98.8 (-1.79%)
Operator

Good day, ladies and gentlemen, and thank you for standing by, and welcome to the Zealand Pharma full year announcement call.

And I would like to hand the call over to your speaker today, Mr. Adam Steensberg, Interim CEO. Thank you. Please go ahead.

Adam Steensberg;S;Interim CEO
Zealand Pharma A;Executive VP and Chief Medical & Development Officer

/- -

Thank you, Bernardo, and welcome, everybody. Joining on today's call is Mats Blom, our CFO.

On Page 1. During today's call, I will begin with a short introduction, and then I'll turn the call over to Mats for a quick summary of the financials for the fourth quarter and the full year ended December 31, 2018. After Mats, I will provide a short update on the clinical progress as well as summarize the outlook and upcoming milestones for Zealand in 2019. We will then open the call for questions.

Please turn to Page 2, where I would like to remind everybody that today's discussions includes forward-looking statements, and that any such statements

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot